Author:
Yu Siyu,Ji Guang,Zhang Li
Abstract
The tumor suppressor p53 is the central hub of a molecular network, which controls cell proliferation and death, and also plays an important role in the occurrence and development of liver fibrosis. The abundant post-translational processing and modification endow the functional diversity of p53. Considering the relationship between p53 and liver fibrosis, drug intervention targeting p53 or management of p53 regulation might be effective strategies to treat liver fibrosis. Here, we systematically discuss the regulation of p53 in different liver cells (hepatocytes, immune cells, HSCs, etc) and the role of p53 in the development of liver fibrosis, and propose possible interventions to prevent the pathogenic processes of liver fibrosis.
Subject
Pharmacology (medical),Pharmacology
Reference67 articles.
1. Cellular mechanisms of liver fibrosis;Acharya;Front. Pharmacol.,2021
2. P53 and proliferating cell nuclear antigen (PCNA) expression in non-tumoral liver diseases;Akyol;Pathol. Int.,1999
3. Telomere dysfunction induces sirtuin repression that drives telomere-dependent disease;Amano;Cell. Metab.,2019
4. Clinical experience with sulbactam/ampicillin in the treatment of obstetric and gynecologic infections. Rio de Janeiro, Brazil, October 25, 1988. Proceedings;Author Anonymous;Suppl. Int. J. Gynecol. Obstet.,1989
5. Liver fibrosis;Aydin;Turk. J. Gastroenterol.,2018
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献